Does perioperative lipid-lowering therapy reduce in-hospital mortality after major noncardiac surgery?

Cavalcanti, Rodrigo B.
August 2004
CMAJ: Canadian Medical Association Journal;8/17/2004, Vol. 171 Issue 4, p328
Academic Journal
Presents a study which discussed whether lipid-lowering therapy (LLT) prevents perioperative cardiovascular events in patients undergoing noncardiac surgery. Comparison of patients who were given primarily statins in the first 2 days after admission with those who were not given primarily statins; Factor associated with LLT use in the first 2 hospital days; Practical implications.


Related Articles

  • Lipid-lowering Drugs.  // Encyclopedic Reference of Molecular Pharmacology;2004, p559 

    A definition of the term "lipid-lowering drugs" is presented. These refers to drugs that affect the lipoprotein metabolism and are used to lower plasma lipids such as cholesterol and triglycerides. Main classes of clinically-used drugs include statins, anion exchange resins fibrates and other...

  • pravastatin. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p622 

    A definition of the term "pravastatin" is presented. It refers to a lipid-lowering drug.

  • Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry. Schaefer, Juergen R.; Gitt, Anselm K.; Sonntag, Frank; Weizel, Achim; Jannowitz, Christina; Karmann, Barbara; Pittrow, David; Bestehorn, Kurt // Vascular Health & Risk Management;2013, Vol. 9, p71 

    Aims: We aimed to document the drug management of patients at high cardiovascular risk in daily practice, with the special focus on lipid-lowering treatment. Methods and results: In this prospective noninterventional study in 2387 outpatient centers throughout Germany, a total of 13,942...

  • Useful Insights on Cholesterol and Drugs. Roberts, H.J. // Nutrition Health Review: The Consumer's Medical Journal;2004, Issue 92, p16 

    This article reports that the magnitude of consumption of cholesterol-lowering drugs is illustrated by the surge in sales of Lipitor® to $6.45 billion for the year 2001. Using the recommendations from the third report of the National Cholesterol Education Program, an estimated 36 million...

  • Pharmaceutical Treatment of Hypertension and Dyslipidemia in people With Diabetes: An Educator's Perspective Part 2: Dyslipidemia. Kruger, Davida F.; Cypress, Marjorie; Maryniuk, Melinda; Childs, Belinda P.; Tieking, Jody // Diabetes Spectrum;Spring2004, Vol. 17 Issue 2, p73 

    Part II. Discusses the pharmacological treatment of dyslipidemia. Evaluation of a case of a 49-year old man with dyslipidemia; Initial interventions for improving lipid profiles; Differences between lipid-lowering agents including statins, niacins, fibrates, bile acid sequestrants and...

  • Statin but not Non-Statin Lipid-Lowering Drugs Decrease Fracture Risk: A Nation-Wide Case-Control Study. Rejnmark, L.; Vestergaard, P.; Mosekilde, L. // Calcified Tissue International;Jul2006, Vol. 79 Issue 1, p27 

    Introduction: Discrepant results have been reported on association between treatment with lipid lowering drugs and fracture risk. Several studies have failed to demonstrate an effect of statins on bone mineral density. Therefore, the epidemiological findings of a reduced fracture risk may be due...

  • Comprehensive lipid management now possible.  // British Journal of Hospital Medicine (17508460);Sep2009, Vol. 70 Issue 9, p496 

    The article investigates the effectiveness of tredative in treating dyslipidaemia. It features the pharmacologic ingredients of tredative including laropiprant and nicotinic acid. In addition, it is considered as more effective in lipid management compared to statin monotherapy. It cites that...

  • Cross sectional survey of effectiveness of lipid lowering drugs in reducing serum cholesterol concentration in patients in 17 general practices. Hippisley-Cox, Julia; Cater, Ruth; Pringle, Mike; Coupland, Carol // BMJ: British Medical Journal (International Edition);3/29/2003, Vol. 326 Issue 7391, p689 

    Abstract Objective: To compare the effectiveness of lipid lowering drugs in lowering serum cholesterol concentrations. Design: Cross sectional study. Setting: 17 practices within 17 primary care groups in Trent region, United Kingdom. Participants: Patients aged 35 years or over taking lipid...

  • Intensive Lipid Management: New Options for Aggressive Risk Reduction. Jacobson, Anne // MD Conference Express;Oct2010, p18 

    The article discusses the uses and trends of intensive lipid-lowering therapies for patients with cardiovascular diseases (CVD) presented by Dr. Robert P. Giugliano during the 25th Annual Caribbean Cardiology Conference. It says that the study on statins for lipid-lowering therapies is the best...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics